Novartis recently received FDA approval to sell a drug aimed at relieving pain for those with sickle cell anemia, and it was first discovered in Oklahoma City.
New FDA-approved drug to treat sickle cell anemia discovered in Oklahoma lab
FDA approves Oklahoma researcher’s new treatment for sickle cell disease
The new drug tackles one of the biggest symptoms of sickle cell disease — horrible pain.
FDA approves new sickle cell drug with Oklahoma roots
Adakveo significantly reduces pain crises in sickle cell patients.
OMRF adds two new principal scientists
OMRF has named Willard “Bill” Freeman and Jacquelyn Gorman to its scientific staff.
OMRF honors board member, reelects chair
OMRF honors board member, reelects chair
OMRF rheumatologist honored by Lupus Foundation of America
OMRF VP of Clinical Affairs Judith James received a pair of distinguished honors at the American College of Rheumatology’s annual meeting.
